Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Novel TK inhibitors with immunosuppressant activity reported by R.W. Johnson

April 16, 1998

New approach to TB vaccination described by Merck

April 16, 1998

Vaccine against pneumococcal disease shown safe and immunogenic in children

April 14, 1998

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

April 9, 1998

BioTransplant and MedImmune announce patent for MEDI-507 and BTI-322 antibodies

April 7, 1998

Interferon-inducing purines disclosed by Japan Energy

April 7, 1998

Pivotal phase III trial of Nabi-StaphVAX now under way

April 6, 1998

NIH offers malaria vaccine technology for licensing

April 3, 1998

Zenapax launched in Switzerland

March 17, 1998

Immunosuppressive analogues of a natural immunostimulant

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...